User:Mohamed Moubarak: Difference between revisions
No edit summary |
|||
| Line 8: | Line 8: | ||
**ECFMG Certificate 2012 | **ECFMG Certificate 2012 | ||
*M.B.Ch.B Cairo University School of Medicine- Egypt 2000-2008 | *M.B.Ch.B Cairo University School of Medicine- Egypt 2000-2008 | ||
==Membership and Honorary/Professional Societies== | |||
Egyptian Society of Cardiology. 2010 – Present | |||
==Work Experience== | ==Work Experience== | ||
*El Gezara Hospital, General practitioner ( | *El Gezara Hospital, General practitioner (Feb2013- July2013)-Egypt | ||
*Sikander Medical Practice, Visiting physician ( | *Sikander Medical Practice, Visiting physician (March2012- June2012),San Antonio,TX-USA | ||
*Egyptian Ministry of Health, General practitioner ( | *Egyptian Ministry of Health, General practitioner (April2011- Jan2012)-Egypt | ||
*Egyptian Military Hospitals, General practitioner ( | *Egyptian Military Hospitals, General practitioner (Dec2009- March2011)-Egypt | ||
==Research Experience== | |||
*Ain Shams University Hospital (July2012-Jan2013) Egypt | |||
**Research Assistant, Dr. Sara H. Farahat, M.D | |||
A Double Blinded comparative study between the effects and the side effects of 400 & 600 Micrograms of Misoprostol given rectally for the prevention of postpartum hemorrhage. After delivery of the infants and within 5 min of clamping and cutting of the cord, women are given 3 tablets either 3 Misotac or 2 Misotac & 1 Placebo rectally (each Misotac tab. Is 200 Microgram of Misoprostol, produced by sigma pharmaceutical industries, SAE, Egypt), the women monitored for postpartum hemorrhage occurrence for 6 hours | |||
*Academy of Scientific Research and Technology (March2008- October2008) Egypt | |||
**Medical Patent examiner, Mr. Mohamed Tarek Hussein- The Head of The Academy | |||
International classification for patents on inventions in the field of medicine. Technical researches in the field of patents on inventions of medicine according to local and international database. Technical reports of the initial technical examination, during this period, i had the online DL-101 certificate of general course of intellectual property from WIPO Academy, Geneva, Switzerland | |||
Revision as of 04:52, 4 September 2013
Mohamed Moubarak, M.D [1]
Mohamed Moubarak is a Research Fellow at PERFUSE core laboratories and Data Coordinating center, Beth Israel Deaconess Medical Center, Harvard Medical School.
Education
- United States Medical License Examination
- ECFMG Certificate 2012
- M.B.Ch.B Cairo University School of Medicine- Egypt 2000-2008
Membership and Honorary/Professional Societies
Egyptian Society of Cardiology. 2010 – Present
Work Experience
- El Gezara Hospital, General practitioner (Feb2013- July2013)-Egypt
- Sikander Medical Practice, Visiting physician (March2012- June2012),San Antonio,TX-USA
- Egyptian Ministry of Health, General practitioner (April2011- Jan2012)-Egypt
- Egyptian Military Hospitals, General practitioner (Dec2009- March2011)-Egypt
Research Experience
- Ain Shams University Hospital (July2012-Jan2013) Egypt
- Research Assistant, Dr. Sara H. Farahat, M.D
A Double Blinded comparative study between the effects and the side effects of 400 & 600 Micrograms of Misoprostol given rectally for the prevention of postpartum hemorrhage. After delivery of the infants and within 5 min of clamping and cutting of the cord, women are given 3 tablets either 3 Misotac or 2 Misotac & 1 Placebo rectally (each Misotac tab. Is 200 Microgram of Misoprostol, produced by sigma pharmaceutical industries, SAE, Egypt), the women monitored for postpartum hemorrhage occurrence for 6 hours
- Academy of Scientific Research and Technology (March2008- October2008) Egypt
- Medical Patent examiner, Mr. Mohamed Tarek Hussein- The Head of The Academy
International classification for patents on inventions in the field of medicine. Technical researches in the field of patents on inventions of medicine according to local and international database. Technical reports of the initial technical examination, during this period, i had the online DL-101 certificate of general course of intellectual property from WIPO Academy, Geneva, Switzerland